初步研究：为非自杀性自伤的青少年住院患者实施 Cut-the-Cut-A 治疗方案。
Pilot Study: Cut the Cut-A Treatment Program for Adolescent Inpatients with Nonsuicidal Self-Injury.
机构信息
Department for Child and Adolescent Psychiatry, ZfP Suedwuerttemberg, CAP, Weingartshoferstrasse 2, 88214, Ravensburg, Germany.
University of Ulm, CAP, Steinhoevelstrasse 5, 89075, Ulm, Germany.
出版信息
Child Psychiatry Hum Dev. 2022 Oct;53(5):928-940. doi: 10.1007/s10578-021-01174-x. Epub 2021 May 3.
Non-suicidal-self-injury (NSSI) in adolescents needing inpatient treatment is a serious health risk behaviour. NSSI-specific treatment programs for inpatients hardly exist. "Cut the Cut" (CTC) is a new treatment program in intervals, addressing this problem. Aim of this pilot-study was to evaluate acceptability and feasibility of CTC. 23 female inpatients (12 CTC, 11 control, aged 15-17; mean = 16.80, SD.70) engaging in NSSI were evaluated for service user satisfaction, frequency, and severity of NSSI at T1 (admission), T2 (discharge after interval 1, CTC-group) and T3 (discharge). A qualitative interview was performed at T3. Significant improvement in NSSI-frequency was given (T1-T3: CTC p = 0.010; control p = 0.038). Severity of NSSI reduced slightly (mild NSSI: CTC p = 0.022, control p = 0.087; severe NSSI: CTC p = 0.111, control p = 0.066). Satisfaction of parents (T3 mean 28.38) and adolescents (T3 mean 26.11) in CTC was rated high. CTC is a feasible treatment option for inpatients engaging in NSSI. Further studies over time are needed.Trial registration Number DRKS00016762, 05.03.2019, retrospectively registered.
非自杀性自伤（NSSI）在需要住院治疗的青少年中是一种严重的健康风险行为。针对住院患者的 NSSI 特定治疗方案几乎不存在。"Cut the Cut"（CTC）是一种新的间隔治疗方案，旨在解决这一问题。本研究旨在评估 CTC 的可接受性和可行性。23 名女性住院患者（12 名 CTC，11 名对照组，年龄 15-17 岁；平均年龄 16.80，标准差.70）参与 NSSI，评估服务使用者的满意度、NSSI 的频率和严重程度，分别在 T1（入院）、T2（间隔 1 后出院，CTC 组）和 T3（出院）进行评估。在 T3 进行了定性访谈。NSSI 频率显著改善（T1-T3：CTC p = 0.010；对照组 p = 0.038）。NSSI 的严重程度略有下降（轻度 NSSI：CTC p = 0.022，对照组 p = 0.087；重度 NSSI：CTC p = 0.111，对照组 p = 0.066）。CTC 中父母（T3 平均值 28.38）和青少年（T3 平均值 26.11）的满意度评价较高。CTC 是住院患者参与 NSSI 的一种可行的治疗选择。需要进一步进行长期研究。试验注册号 DRKS00016762，2019 年 3 月 5 日，回顾性注册。
Zotero 插件